WHO offers experimental therapeutics in North Kivu – Kinshasa Times

Others



[ad_1]

Recently, the health ministry of the Democratic Republic of Congo (DRC) Oly Ilunga announced the start of a multi-drug trial for Ebola treatment in North Kivu.

On Tuesday, November 27, in a statement to the Kinshasa Times, the World Health Organization (WHO) said that experimental Ebola therapies are now being set up in North Kivu.

To treat the Ebola virus, it is reported, patients were subjected to "compbadionate use protocol, with promising drugs and a good safety profile in the laboratory".

" Until now, patients have been treated according to a compbadionate use protocol, with promising drugs and a good safety profile in the laboratory. The giant step the DRC is taking now will clarify what works best and save many lives in the years to come Said the Director General of the World Health Organization (WHO), Dr. Tedros Adhanom Ghebreyesus.

According to WHO, already more than 160 patients have been treated with experimental therapeutics in an ethical framework developed by WHO, in consultation with experts in the field and in the DRC, called Emergency Surveillance Use of Interventions unregistered and experimental experiments (MEURI).

In addition, Oly Ilunga says that these trials will contribute to the acquisition of this knowledge, while continuing to intervene on all fronts to put an end to the current epidemic. And attested that "our country is too often hit by Ebola outbreaks, which also means we have unique expertise to fight it."

The Ministry of Health reports that since the beginning of the epidemic in North Kivu, the cumulative number of cases is 419, of which 372 are confirmed and 47 are probable. In total, there were 240 deaths (193 confirmed and 47 probable) and 123 people cured.